Stephen J. Mock
Public Communications Contact at PAR PHARMACEUTICAL COMPANIES, INC.
Profile
Stephen J.
Mock is currently the Vice President of Corporate Affairs at Endo Generics Holdings, Inc. Previously, he held the position of Senior Vice President of Investor Relations and Corporate Affairs at Endo International Plc.
Stephen J. Mock active positions
Companies | Position | Start |
---|---|---|
PAR PHARMACEUTICAL COMPANIES, INC. | Public Communications Contact | - |
Former positions of Stephen J. Mock
Companies | Position | End |
---|---|---|
ENDO INTERNATIONAL PLC | Investor Relations Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Endo Generics Holdings, Inc.
Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Stephen J. Mock